HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides

Immunogenetics

Volumn 49, Issue 9, 1999, Pages 800-807

  Clot, Fabienne ^a,b   Gianfrani, Carmen ^c,d   Babron, Marie Claude ^e   Bouguerra, Faouzi ^f   Southwood, Scott ^d   Kagnoff, Martin F ^g   Troncone, Riccardo ^h   Percopo, Selvaggia ^h   Eliaou, Jean François ^b   Clerget Darpoux, Françoise ^e   Sette, Alessandro ^d   Greco, Luigi ^h  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL SAINT ELOI   (France)

^c CNR   (Italy)

^d Epimmune   (United States)

^e INSERM   (France)

^f CHILDREN S HOSPITAL   (Tunisia)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Binding; Celiac disease; DR53; Gliadin peptides; HLA association

Indexed keywords

GLIADIN; HLA DQ ANTIGEN; HLA DR5 ANTIGEN; SYNTHETIC PEPTIDE;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CELIAC DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR;

BINDING, COMPETITIVE; CELIAC DISEASE; COHORT STUDIES; DIMERIZATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIADIN; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ITALY; PROTEIN BINDING; RISK FACTORS; TUNISIA;

EID: 0032800261     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050554     Document Type: Article

References (47)

1. Bouguerra F, Babron MC, Eliaou JF, Debbabi A, Clot J, Greco L, Clerget-Darpoux F (1997) Synergistic effect of two HLA heterodimers in the susceptibility to celiac disease in Tunisia. Genet Epidemiol 14:413-422
2. Buus S, Sette A, Colon SM, Miles C, Grey HM (1987) The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353-1358
3. Clerget-Darpoux F, Bouguerra F, Kastally R, Semana G, Babron MC, Debbabi A, Bennaceur B, Eliaou JF (1994) High risk genotypes for celiac disease. C R Acad Sci Paris, Life Sciences 317:931-936
4. Colonna M, Mantovani W, Corazza GR, Barboni P, Gasbarrini G, Ferrara GB, Tosi R, Tanigaki N (1990) Reassessment of HLA association with celiac disease in special reference to the DP association. Hum Immunol 29:263-274
5. Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, La Nasa G, Mulargia M, Pirastu M, Cao A, De Virgiliis S (1992) A high frequency of the A30, B18, DR3, DRw52 DQw2 extended haplotype in Sardinian celiac disease patients : further evidence that disease susceptibility is conferred by DQA1*0501, DQB1*0201. Tissue Antigens 39:78-83
6. Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, Cao A, De Virgiliis S (1994) A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 40:138-142
7. De Marchi M, Borelli I, Olivetti E, Richiardi P, Wright P, Ansaldi N, Barbera C, Santini B (1979) Two HLA-DR alleles are associated with celiac disease. Tissue Antigens 14:309-316 (1979)
8. Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Chaves-Vieira ML, Bach JF (1994) Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum Immunol 40:8-16
9. Eliaou JF, Humbert M, Balaguer P, Gebuhrer L, Amsellem S, Bétuel H, Nicolas JC, Clot J (1989) A method of HLA class II typing using non radioactive labelled oligonucleotides. Tissue Antigens 33:475-485
10. Eliaou JF, Palmade F, Avinens O, Eduard E, Balaguer P, Nicolas JC, Clot J (1992) Genetic HLA-DRB1 oligotyping by a non-radioactive reverse dot-blot methodology. Hum Immunol 35:215-222 (1992)
11. Falchuk ZM, Rogentine GN, Stober W (1972) Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest 51:1602-1606
12. Ferrante P, Petronzelli F, Mariani P, Bonmico M, Mazzilli MC (1992) Oligotyping of Italian celiac patients with the 11th International Histocompatibility Workshop reagents. Tissue Antigens 39:38-39
13. Franco A, Appella E, Kagnoff MF, Chowers Y, Sakaguchi K, Grey HM, Sette A (1994) Peripheral T cell response to A-gliadin in celiac disease: differential processing and presentation capacities of Epstein-Barr-transformed B cells and fibroblasts. Clin Immunol Immunopathol 71:75-81
14. Fugger L, Svejgaard A (1997) The HLA-DQ7 and DQ8 associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature. Tissue Antigens 50:494-500
15. Gorga JC, Horejsi V, Johnson DR, Raghupathy R, Strominger JL (1987) Purification and characterization of class II histocompatibility antigens from a homozygous human B cell lines. J Biol Chem 262:16087
16. Herrera M, Augustovski TF, Chertkoff L, Fainboim L, De Rosa S, Cowan EP, Satz ML et al. (1994) Molecular characterization of HLA class II genes in celiac disease patients of Latin American caucasian origin. Tissue Antigens 43:83-87
17. Hmida S, Gauthier A, Quivilic F, Genetet B, Boukef K, Semana G (1995) HLA class II gene polymorphism in Tunisians. Tissue Antigens 45:63-68
18. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (1991) (eds) HLA. Oxford University Press, Oxford, pp 1065-1220
19. Johansen BE, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KEA, Sollid LM (1996) Binding of peptides from the N-terminal region of α-gliadin to the celiac disease-associated HLA-DQ2 molecule assesed in biochemical and T cell assays. Clin Immunol Immunopathol 79:288-293 (1996)
20. Kagnoff MF, Harwood JI, Bugawan TL, Erlich HA (1989) Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Proc Natl Acad Sci 86:6274-6278
21. Kagnoff MF (1992) Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components. Gastroenterol Clin North Am 21:405-425
22. Kobayashi H, Kokubo T, Abe Y, Sato K, Kimura S, Miyokawa N, Katagiri M (1996) Analysis of anchor residues in a naturally processed HLA-DR53 ligand. Immunogenetics 44:366-371
23. Lundin KEA, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM (1993) Gliadin-specific, HLA-DQ(α1*0501,β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 188:187-196
24. Lundin KEA, Scott H, Fausa O, Thorsby E, Sollid LM (1994) T cells from the small intestinal mucosa of a DR4,DQ7/ DR4,DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 41:285-291
25. Mantovani V, Corazza GR, Angelini G, Delfino L, Frisoni M, Mirri P, Valentini RA, Barboni P, Gasbarrini G, Ferrara GB (1991) Molecular analysis of HLA-DQA alleles in coeliac disease lack of a unique disease-associated sequence. Clin Exp Immunol 83:74-78
26. Mazzilli MC, Ferrante P, Mariani P, Martone M, Petronzelli F, Triglione P, Bonamico M (1992) A study of Italian pediatric celiac disease patients confirms that the primary HLA association is the DQ(α1*0501,β1*0201) heterodimer. Hum Immunol 33:133-139
27. Meeuwisse GW (1970) Diagnostic criteria in celiac disease. Acta Paediatr Scand 59:461-463
28. Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KEA, Sjorstrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717
29. Naruse TK, Ando R, Nose Y, Kagiya M, Ando H, Kawata H, Nabeya N, Isshiki G, Inoko H (1997) HLA-DRB4 genotyping by PCR-RFLP: diversity in the associations between HLA-DRB4 and DRB1 alleles. Tissue Antigens 49:152-159
30. Ploski R, Thorsby E, Sollid LM (1993) On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41:173-77
31. Rammensee HG, Friede T, Stevanović S (1995) MHC ligands and peptide motif: first listing. Immunogenetics 41:178-228
32. Robbins F, Hurley CK, Tang T, Yao H, Lin YS, Wade J, Goeken N, Hartzman RJ (1997) Diversity associated with the second expressed HLA-DRB locus in the human population. Immunogenetics 46:104-110
33. Sette A, Buus S, Colon SM, Miles C, Grey HM (1989) Structural analysis of peptides capable of binding to more than one Ia antigen. J Immunol 142:35-40
34. Sette A, Southwood S, O'Sullivan D, Gaeta FCA, Sidney J, Grey HM (1992) Effect of PH on MHC class II-peptide interaction. J Immunol 148:844-851
35. Sollid LM, Markussen G, Ek J, Gjerde H, Vardal F, Thorsby E (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 169:345-350
36. Sollid LM, Thorsby E (1990) The primary association of celiac disease to a given HLA-DQα/β heterodimer explains the divergent HLA-DR association observed in various Caucasian population. Tissue Antigens 36:136-137
37. Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A (1998) Several common HLA-DR types share a largely overlapping peptide binding repertoire. J Clin Inv 160:3363-3373
38. Sutton VR, Kienzle BK, Knowles RW (1989) An altered splice site is found in the DRB4 gene that is not expressed in HLA-DR7, Dw11 individuals. Immunogenetics 29:317-322
39. Sutton VR, Knowles RW (1990) An aberrant DRB4 null gene transcript is found that could encode a novel HLA-DR β-chain. Immunogenetics 31:112-117
40. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ (1992) HLA class II alleles associated with celiac disease susceptibility in a Southern Europe population. Tissue Antigens 40:90-7
41. Tosi R, Vismara D, Tanigaki N, Ferrara GB, Cicimarra F, Buffolano W, Follo D, Auricchio S (1983) Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 28:395-404
42. Tosi R, Tanigaki N, Polanco I, De Marchi M, Woodrow JC, Hetzel PA (1986) A radioimmunoassay typing study of non-DQw2-associated celiac disease. Clin Immunol Immunopathol 39:168-172
43. Troncone R, Gianfrani C, Mazzarella G, Greco L, Guardiola J, Auricchio S, De Bernardinis P (1998) The majority of gliadin-specific T cell clones from the coeliac small intestinal mucosa produce both γ-interferon and IL4. Dig Dis Sci 43:156-161
44. Valli A, Sette A, Kappos S, Oseroff C, Sideney J, Miescher G, Hochbergger M, Albert ED, Adorini L (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91:616-628
45. Van de Kamer JH, Weijers HA, Dicke WK (1953) Acta Pædiatr 42:223-231
46. Van de Wal Y, Kooy YMC, van Veelen PA, Pena SA, Mearin LM, Molberg O, Lundin KEA, Sollid LM, Mutis T, Benckhuijsen WE, Drijfhout JW, Koning F (1998a) Proc Natl Acad Sci 95:10050-10054
47. Van de Wal Y, Kooy YMC, van Veelen PA, Pena SA, Mearin LM, Papadopoulos G, Koning F (1998b) Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin specific T cell reactivity. J Immunol 161:1585-1588